NEW YORK (GenomeWeb) – San Francisco-based genetic testing company Invitae has filed a prospectus for an initial public offering of its stock for up to $86 million.

Invitae has not priced its shares nor said how many it plans to offer, but said in its Form S-1 filed with the US Securities and Exchange Commission that it plans to trade on the New York Stock Exchange under the symbol "NVTA."

JP Morgan Securities, Cowen and Company, and Leerink Partners are listed as underwriters.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.